Federated Hermes, Inc. Frequency Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.88 - $3.85 $23,383 - $47,886	-12,438 Reduced 0.94%	1,311,580 $5.05 Million
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $332,386 - $580,538	-227,662 Reduced 14.67%	1,324,018 $2.37 Million
Q2 2022 Aug 15, 2022	SELL	$1.03 - $2.03 $1.46 Million - $2.88 Million	-1,416,366 Reduced 47.72%	1,551,680 $2.33 Million
Q1 2022 May 13, 2022	BUY	$1.7 - $5.72 $283,866 - $955,125	166,980 Added 5.96%	2,968,046 $6.29 Million
Q4 2021 Feb 14, 2022	BUY	$4.95 - $7.11 $1.13 Million - $1.63 Million	228,553 Added 8.88%	2,801,066 $14.4 Million
Q3 2021 Nov 15, 2021	BUY	$6.96 - $9.25 $3.65 Million - $4.86 Million	525,113 Added 25.65%	2,572,513 $18.2 Million
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $9.38 Million - $13.5 Million	-1,164,984 Reduced 36.27%	2,047,400 $20.4 Million
Q1 2021 May 13, 2021	BUY	$7.99 - $55.01 $14.9 Million - $103 Million	1,869,484 Added 139.21%	3,212,384 $30.5 Million
Q4 2020 Feb 12, 2021	SELL	$18.65 - $40.0 $373,000 - $800,000	-20,000 Reduced 1.47%	1,342,900 $47.4 Million
Q3 2020 Nov 12, 2020	BUY	$17.76 - $24.96 $71,040 - $99,840	4,000 Added 0.29%	1,362,900 $26.2 Million
Q2 2020 Aug 13, 2020	SELL	$14.65 - $24.9 $847,326 - $1.44 Million	-57,838 Reduced 4.08%	1,358,900 $31.6 Million
Q1 2020 May 13, 2020	BUY	$16.36 - $27.55 $717,189 - $1.21 Million	43,838 Added 3.19%	1,416,738 $25.2 Million
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $17.4 Million - $25.7 Million	1,372,900 New	1,372,900 $24.1 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.